It is common for sponsors to switch digital platforms between clinical trial phases, but sponsors can achieve much by using ...
Immutep has concluded subject enrolment in the Phase II segment of the AIPAC-003 trial of eftilagimod alpha (efti) to treat ...
The trial enrolled individuals with EGFRm, locally advanced or metastatic non-squamous non-small cell lung cancer. Credit: kvi123/Shutterstock. Summit Therapeutics has concluded subject enrolment in ...
ProPharma is a global research consulting company and a Dual-Category Award Winner in the 2024 Clinical Trials Arena Excellence Awards. ProPharma, a global research consulting company headquartered in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback